Skip to main content
Bayer AG logo

Bayer AG — Investor Relations & Filings

Ticker · BAY ISIN · DE000BAY0017 LEI · 549300J4U55H3WP1XT59 F Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2022-11-08 Interim / Quarterly Rep…
Country DE Germany
Listing F BAY

About Bayer AG

https://www.bayer.com/en/

Bayer AG is a global life science company with core competencies in the fields of healthcare and nutrition. Guided by its mission "Health for all, Hunger for none," the company develops products and services to address fundamental human needs and global challenges. Its operations are divided into three main divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, which offers over-the-counter medications and supplements; and Crop Science, which provides tailored solutions for farmers including seeds, crop protection, and digital farming technologies. Bayer's activities encompass the discovery, development, manufacturing, and commercialization of its product portfolio, aiming to improve quality of life and ensure a sustainable supply of food and feed.

Recent filings

Filing Released Lang Actions
Q3 statement / Q3 financial report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for the third quarter of 2022 for the Bayer Group. It contains comprehensive financial data, including sales, EBITDA, EBIT, net income, and cash flow, along with detailed management commentary on performance, key events, and divisional results. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2022
2022-11-08 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Audit Report / Information Classification · 95% confidence The document is titled 'Finanzbericht' (Financial Report) and explicitly references 'Bekanntmachung nach §§ 264 Abs. 3, 325 HGB zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022'. The content details the invocation of exemptions under German Commercial Code (§ 264 Abs. 3 HGB) for the fiscal year ending 2022, specifically concerning the inclusion of subsidiaries in the consolidated financial statements of Bayer Aktiengesellschaft, which will be published in the Federal Gazette (Bundesanzeiger). This type of filing, which relates to the formal publication and accounting treatment of annual financial statements under German law (HGB), is best classified as an Audit Report/Information (AR) or potentially a specific regulatory disclosure related to annual reporting, but given the focus on the formal disclosure of the financial reporting status rather than the full report itself, and the lack of a specific German equivalent code, 'AR' (Audit Report / Information) is the closest fit among the provided options for formal annual financial disclosures that are not the full 10-K or a simple earnings release. However, since this is a formal disclosure about the *application of accounting principles/exemptions* related to the annual financial statements, and not the audit report itself, it strongly relates to the formal annual reporting structure. Given the options, and recognizing this is a formal disclosure related to the annual financial reporting cycle, 'AR' is chosen as the most appropriate category for formal financial reporting documentation that isn't the full 10-K or a simple ER. FY 2022
2022-11-07 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Regulatory Filings Classification · 92% confidence The document is very short (607 characters) and appears to be a formal resolution or decision ('Gesellschafterbeschluss' - Shareholders' Resolution) by the sole shareholder of Bayer 04 Immobilien GmbH. Specifically, it states that the company is invoking the exemption provisions of § 264 Abs. 3 HGB (German Commercial Code) for the fiscal year 2022. This relates to exemptions from certain disclosure requirements, often associated with smaller entities or subsidiaries. This type of formal, specific legal/accounting decision that isn't a full report (10-K, IR) or a standard management announcement (MANG) fits best under the general 'Regulatory Filings' (RNS) category, as it is a formal statutory filing/notice, or potentially a specific legal/governance filing. Given the options, RNS serves as the best catch-all for specific statutory notices that don't match the other defined categories like Audit Report (AR) or Governance (CGR). It is not an AGM resolution, dividend notice, or earnings release.
2022-08-22 German
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.06.2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for Bayer AG for the period 01.01.2022 to 30.06.2022. It contains comprehensive financial statements, including income statements, balance sheet data, and detailed management analysis of the financial results (Konzernzwischenlagebericht). It is not an announcement of a report, but the report itself, containing substantive financial data and analysis for an interim period. H1 2022
2022-08-04 German
Half-yearly financial report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-Year Financial Report 2022' and contains comprehensive financial statements, including consolidated income statements, statements of financial position, and cash flows for the period ending June 30, 2022. It includes an 'Interim Group Management Report' and detailed financial data tables. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial analysis and statements for a period shorter than a full fiscal year. H1 2022
2022-08-04 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Governance Information Classification · 85% confidence The document is a short, formal shareholder resolution (Gesellschafterbeschluss) from Bayer 04 Leverkusen regarding the application of exemption provisions under German commercial law (HGB) for the 2022 fiscal year. It does not contain full financial statements or a comprehensive report, but rather a specific corporate governance/regulatory filing regarding reporting exemptions. As it does not fit into specific categories like 10-K or IR, and is a formal regulatory notice, it is best classified as a general regulatory filing.
2022-07-20 German

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.